Glossopharyngeal nerve paralysis
diseaseOn this page
Also known as cranial nerve palsy of glossopharyngeal nerveglossopharyngeal nerve cranial nerve palsy
Summary
Glossopharyngeal nerve paralysis (MONDO:0002781) is a disease. A subtype of glossopharyngeal nerve disorder — broader associated-gene and molecular evidence is on the parent page (see Disease family below).
Clinical features
No curated clinical features (Orphanet) for this disease.
Identifiers
Disease identifiers
| Field | Value |
|---|---|
| Canonical name | glossopharyngeal nerve paralysis |
| Mondo ID | MONDO:0002781 |
| DOID | DOID:3816 |
| NCIT | C27335 |
| UMLS | C5231192 |
| MedGen | 1696475 |
| Anatomy (UBERON) | UBERON:0001649 |
| Is cancer (heuristic) | no |
Also known as: cranial nerve palsy of glossopharyngeal nerve · glossopharyngeal nerve cranial nerve palsy
Disease family
Classification path: disease › human disease › disease by body system or component › nervous system disorder › cranial nerve neuropathy › glossopharyngeal nerve disorder › glossopharyngeal nerve paralysis
Related subtypes (4): vagus nerve disorder, glossopharyngeal nerve neoplasm, glossopharyngeal motor neuropathy, glossopharyngeal neuralgia
Genetics & variants
GWAS landscape
No GWAS associations recorded — common-variant (GWAS) studies don’t cover this disease (typical for Mendelian / rare diseases). See the curated gene cohort and Mendelian overlap below.
Variant details and genetic-evidence tiers
No tiered GWAS variants or ClinVar records for this disease.
Genes & proteins
No associated-gene cohort resolved for this disease. Atlas builds the molecular and therapeutic sections — associated genes, protein families, druggability, pathways, interactions, and drug associations — by aggregating over a disease’s associated genes (resolved via GWAS / GenCC / ClinVar / CIViC), and none resolved here. This is expected for antibody-mediated, autoimmune, or otherwise non-gene-defined conditions; the curated evidence for this disease is its clinical features, GWAS susceptibility, and clinical trials (above).
Function
No pathway enrichment — requires an associated-gene cohort.
Therapeutics
No druggable-target or therapeutic data for this disease’s cohort.
Clinical trials & evidence
Clinical trials
Clinical trials: 0.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.